Medtronic is a multinational medical technology company that develops and manufactures medical devices and therapies. The company operates in various segments, including Cardiac and Vascular Group, Minimally Invasive Therapies Group, Restorative Therapies Group, and Diabetes Group.

From 2006 to 2022, Medtronic experienced overall revenue growth, driven by factors such as technological advancements, product innovation, acquisitions, and an aging population's increasing healthcare needs. It's important to note that revenue can be affected by multiple factors, including fluctuations in currency exchange rates, changes in healthcare policies, and market dynamics.

From 11.3 billion dollars in 2006 to over 31 billion dollars in 2022, Medtronic's revenue has increased. Medtronic is a company that works in a wide range of specialties and industries, such as diabetes and cardiovascular care, among others. The organization's functional settle is in Minneapolis, Minnesota, as of now creating the biggest piece of its incomes in the US. However, Medtronic moved its legal headquarters to Dublin, Ireland, in 2015 for tax reasons.

To obtain the specific revenue figures for Medtronic during this period, I recommend referring to their official financial statements, annual reports, or reliable financial databases that provide historical financial data for public companies. These sources will provide you with accurate and up-to-date information on Medtronic's revenue over the years.

To obtain the specific revenue figures for Medtronic during this period,Read GlobalData Plc’s newest AI Executive Briefing report:
For Disruptor clients ? https://shorturl.at/iKRTW
For everyone else ? https://shorturl.at/mtuB2